Published on
July 25, 2024
- 17:13 GMT
UNIVERSITY OF PITTSBURGH EXECUTES CONTRACT TO DESIGN CLINICAL TRIAL FOR NEUROSOLV PERINELINE™ SPINAL CORD INJURY THERAPY
NeuroSolv, a spinal cord injury drug developer, signed a contract with the University of Pittsburgh to design a clinical trial for its drug therapy, Perineline. BELFAST, CO. DUBLIN, UNITED KINGDOM, July 25, 2024 /EINPresswire.com/ -- UNIVERSITY OF …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
